Literature DB >> 30720123

Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.

Antje Güttler1, Katharina Theuerkorn1, Anne Riemann2, Henri Wichmann1, Jacqueline Kessler1, Oliver Thews2, Matthias Bache1, Dirk Vordermark1.   

Abstract

Hypoxia‑induced carbonic anhydrase IX (CAIX) is involved in intracellular and extracellular pH regulation, which is critical for tumor growth and metastasis. CAIX is overexpressed in breast cancer and is associated with the poor survival of patients after radiotherapy. Therefore, we evaluated the cellular and radiobiological effects of CAIX inhibition in human breast cancer cells. We used CA9 siRNA and the CA inhibitor (CAI) U104, respectively, to inhibit CAIX expression and activity in basal triple‑negative MDA‑MB‑231 and luminal MCF‑7 cells under hypoxic conditions. We investigated the effects of CAIX inhibition on CA9 mRNA and CAIX protein level, as well as on CAIX activity, intracellular pH, proliferation, apoptosis, clonogenic survival, migration, cell cycle distribution and radiosensitivity. CA9 siRNA and CAI U104 decreased CA9 mRNA and CAIX protein level in MDA‑MB‑231 and MCF‑7 cells. Furthermore, incubation with CAI U104 significantly decreased carbonic anhydrase activity and reduced the intracellular pH. Additionally, CA9 siRNA or U104 reduced clonogenic survival, migration and the number of cells in the G0/G1 phase, induced apoptosis and demonstrated additive or synergistic effects in combination with irradiation. In conclusion, combination of CAIX inhibition and irradiation is a promising treatment strategy against breast cancer with hypoxia‑induced CAIX expression.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30720123     DOI: 10.3892/or.2019.7001

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents.

Authors:  Mikhail Krasavin; Stanislav Kalinin; Tatiana Sharonova; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

2.  Influence of Paclitaxel and Doxorubicin Therapy of ßIII-Tubulin, Carbonic Anhydrase IX, and Survivin in Chemically Induced Breast Cancer in Female Rat.

Authors:  Alena Pastornická; Silvia Rybárová; Slávka Drahošová; Jozef Mihalik; Andrea Kreheľová; Andriana Pavliuk-Karachevtseva; Ingrid Hodorová
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

3.  Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells.

Authors:  Ebru Temiz; Ismail Koyuncu; Mustafa Durgun; Murat Caglayan; Ataman Gonel; Eray Metin Güler; Abdurrahim Kocyigit; Claudiu T Supuran
Journal:  Int J Mol Sci       Date:  2021-06-05       Impact factor: 5.923

Review 4.  Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers.

Authors:  Kaye J Williams; Roben G Gieling
Journal:  Int J Mol Sci       Date:  2019-12-02       Impact factor: 5.923

Review 5.  Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.

Authors:  Alessio Nocentini; Andrea Angeli; Fabrizio Carta; Jean-Yves Winum; Raivis Zalubovskis; Simone Carradori; Clemente Capasso; William A Donald; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 6.  Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors.

Authors:  Claudiu T Supuran
Journal:  J Exp Pharmacol       Date:  2020-12-15

7.  Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in vitro and in vivo studies.

Authors:  Chandra Bhushan Mishra; Raj Kumar Mongre; Amresh Prakash; Raok Jeon; Claudiu T Supuran; Myeong-Sok Lee
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

8.  Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines.

Authors:  Silvia Mussi; Sara Rezzola; Paola Chiodelli; Alessio Nocentini; Claudiu T Supuran; Roberto Ronca
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

9.  Inhibition of Carbonic Anhydrase IX Suppresses Breast Cancer Cell Motility at the Single-Cell Level.

Authors:  Agne Janoniene; Linas Mazutis; Daumantas Matulis; Vilma Petrikaite
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

10.  Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition.

Authors:  Mohamed T M Nemr; Asmaa M AboulMagd; Hossam M Hassan; Ahmed A Hamed; Mohamed I A Hamed; Mohamed T Elsaadi
Journal:  RSC Adv       Date:  2021-08-01       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.